[1] LI YH,ZHANG H,XIONG SX. The effects of miR-125a in inhibiting the invasion,proliferation and migration of hepatocellular carcinoma cells-HepG2 by down-regulating the expression of VEGF[J]. Hebei Med J,2019,41(16):2405-2410.(in Chinese)李贻弘,张宏,熊首先.miR-125a下调血管因子VEGF抑制肝癌细胞的侵袭、增殖、迁移及周期S期[J].河北医药,2019,41(16):2405-2410.
|
[2] DENG XJ,GONG SX,YANG SH,et al. MicroRNA-539 inhibiting the occurrence and development of hepatocellular carcinoma by targeting E2F transcription factor 3[J]. Acta Anatomica Sinica,2018,49(4):469-474.(in Chinese)邓学军,龚邵新,杨胜辉,等.MicroRNA-539靶向调控E2F转录因子3抑制肝癌的发生与发展[J].解剖学报,2018,49(4):469-474.
|
[3] LILIAN AM,SIMONE CS,DANIELE S,et al. Comparison of the effects of monastrol and oxomonastrol on human hepatoma cell line HepG2/C3A[J]. Anticancer Res,2017,37(3):1197-1204.
|
[4] WENBIN W,XIAO Y,AMAN X,et al. Human cancer cells suppress behaviors of endothelial progenitor cells through miR-21targeting IL6R[J]. Microvascular Res,2018,120:21-28.
|
[5] SUN N,ZHANG G,LIU Y. Long non-coding RNA XIST sponges miR-34a to promotes colon cancer progression via Wnt/β-catenin signaling pathway[J]. Gene,2018,30(665):141-148.
|
[6] LI X,LUO XL. Research progress of miRNAs regulating tumor microenvironment[J]. Curr Immunol,2019,39(3):245-248.(in Chinese)李欣,罗小玲.miRNA调控肿瘤微环境的研究进展[J].现代免疫学,2019,39(3):245-248.
|
[7] NATHAN WW,YUHAO C,SHUAI C,et al. OncomiR:An online resource for exploring pan-cancer microRNA dysregulation[J]. Bioinformatics,2017,34(4):713-715.
|
[8] ZHAO YL,WANG HB,MAO TZ,et al. Research progress on the relationship between microRNA and tumor[J]. Oncol Prog,2019,17(12):1365-1367,1384.(in Chinese)赵银龙,王洪冰,毛铁铸,等.microRNA与肿瘤关系的研究进展[J].癌症进展,2019,17(12):1365-1367,1384.
|
[9] CAO YG,XIA GB,GUO J,et al. Effect of miR-939-5p on the migration and proliferation of hepatocellular carcinoma by regulating the expression of USP22 gene[J]. Int J Surg,2019,46(2):119-123.(in Chinese)曹玉刚,夏国兵,郭浚,等.miR-939-5p调控USP22基因表达对肝癌迁移和增殖的影响[J].国际外科学杂志,2019,46(2):119-123.
|
[10] SONG Y,XU Y,WANG Z,et al. MicroRNA-148b suppresses cell growth by targeting cholecystokinin-2 receptor in colorectal cancer[J]. Int J Cancer,2012,131(5):1042-1051.
|
[11] YAO LH,WANG GR,CAI Y,et al. The expressions and diagnostic values of miR-18a and miR-21 in esophageal cancer[J]. Chin J Oncol,2019,41(2):107-111.(in Chinese)姚丽华,汪光蓉,蔡燕,等.miR-18a和miR-21在食管癌中的表达及其对食管癌的诊断价值[J].中华肿瘤杂志,2019,41(2):107-111.
|
[12] XU DW,MA PJ,GAO GJ,et al. The effect of long non-coding RNA MEG3 on cell proliferation,migration and invasion of glioma cell line U251 via targeting miR-21[J]. J Chin Oncol,2019,25(6):524-530.(in Chinese)徐大伟,马鹏举,高国军,等.长链非编码RNA MEG3靶向miR-21对胶质瘤U251细胞增殖、侵袭和迁移的影响[J].肿瘤学杂志,2019,25(6):524-530.
|
[13] XIN R,LI D,XU HY,et al. Influence of miRNA-21 in radiosensitivity of breast cancer cells and its mechanism[J]. J Jilin Univ(Med Edit),2019,45(4):772-778.(in Chinese)信瑞,李冬,徐慧英,等.miRNA-21对乳腺癌细胞放射敏感性的影响及其机制[J].吉林大学学报(医学版),2019,45(4):772-778.
|
[14] XIE RT,CONG XL,ZHONG XM,et al. MicroRNA-33a downregulation is associated with tumorigenesis and poor prognosis in patients with hepatocellular carcinoma[J]. Oncol Lett,2018,15(4):4571-4577.
|
[15] HUANG X. Advances of microRNAs in translational medicine and immunotherapy of renal tumors[J]. J Int Transl Med,2016,4(2):103-108.
|
[16] LIU F,LIANG GD,WANG Y,et al. Expression of miR-21 in hepatocellular carcinoma and its correlation with prognosis[J]. Chin J Gerontol,2016,36(1):115-116.(in Chinese)刘峰,梁国栋,王岩,等.肝细胞肝癌组织中miR-21表达水平及与预后的相关性[J].中国老年学杂志,2016,36(1):115-116.
|
[17] PU CW,HUANG H,WANG ZD,et al. Extracellular vesicleassociated miR-21 and miR-144 are markedly elevated in serum of patients with hepatocellular carcinoma[J]. Front Physiol,2018,9:930.
|
[18] WANG WY,ZHANG HF,TANG M,et al. Expression of miR-21 in liver cancer and its relationship with PTEN[J]. Chin J Gen Surg,2017,26(3):395-400.(in Chinese)王文耀,张鸿飞,唐淼,等.miR-21在肝癌中的表达及其与PTEN的关系[J].中国普通外科杂志,2017,26(3):395-400.
|
[19] ZHANG Q,LI XT,CHEN Y,et al. Wnt/β-catenin signaling mediates the suppressive effects of diallyl trisulfide on colorectal cancer stem cells[J]. Cancer Chemoth Pharm,2018,81:969-977.
|
[20] FAN LK,MA C. Recombinant human DKK1 protein in oral squamous cell carcinoma stem cell migration and invasion role[J]. Clin J Med Offic,2018,46(2):187-190.(in Chinese)范龙坤,马超.人重组蛋白DKK1对口腔鳞癌干细胞迁移及侵袭能力作用[J].临床军医杂志,2018,46(2):187-190.
|
[21] LUSTIG B,BEHRENS J. The Wnt signaling pathway and its role in tumor development[J]. J Cancer Res Clin Oncol,2003,129(4):199-221.
|
[22] LI H,ZHOU DJ. Wnt2/β-catenin signaling pathway and its role in tumors[J]. Guangdong Med J,2015,36(2):320-323.(in Chinese)李华,周德俊.Wnt2/β-catenin信号通路及其在肿瘤中的作用[J].广东医学,2015,36(2):320-323.
|
[23] SUN F,WANG JZ,LUO JJ,et al. MiR-21 and miR-130b targeted artificially designed circRNAs inhibit epithelial-mesenchymal transition in liver cancer cells[J]. Chin Med Dev,2018,33(1):52-54.(in Chinese)孙芳,王金枝,罗吉君,等.miR-21和miR-130b靶向性人工设计circRNA抑制肝癌细胞上皮间质转化[J].中国医疗设备,2018,33(1):52-54.
|
[24] LIU KM,GUO L,XI T. Mechanism of ursolic acid inducing apoptosis of liver cancer HepG2 cells by inhibiting miR-21 expression[J]. J Chin Pharm Univ,2015,6(6):108-113.(in Chinese)刘昆梅,郭乐,奚涛.乌索酸通过抑制miR-21表达诱导肝癌HepG2细胞凋亡的机制[J].中国药科大学学报,2015,6(6):108-113.
|